Results 1 to 10 of about 4,991 (157)

Diagnostic Challenges in Visceral Leishmaniasis in a 17-Month-Old Female: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Visceral leishmaniasis is an uncommon infectious disease. In this report, we present a case of VL in a 17‐month‐old child who presented with a fever and splenomegaly. After the patient failed to respond to several courses of antibiotics, a bone marrow aspirate confirmed the definitive diagnosis of VL, which was successfully treated with ...
Sobeh AS, Soufan M, Sarakbi T, Jaddouh A, Alharroush F.   +4 more
europepmc   +2 more sources

In Situ Evaluation of Macrophage Populations and Inflammasome Components in Cutaneous and Mucocutaneous Leishmaniasis. [PDF]

Parasite Immunol
ABSTRACT American tegumentary leishmaniasis (ATL) affects the skin and mucous membranes, with a spectrum shaped by Th1/Th2 responses. This study investigated inflammasome activation in correlation with macrophage subpopulations, tissue parasitism, and histological changes in cutaneous and mucocutaneous leishmaniasis. We assessed inflammasome activation,
de Heleno Chagas de Carvalho C, Araujo Flores GV, Sandoval Pacheco CM, da Ribeiro da Matta VL, de Esteves de Morais C, Romiti R, Belda Júnior W, Dalastra Laurenti M.   +7 more
europepmc   +2 more sources

Treatment strategies for mucocutaneous leishmaniasis

Journal of Global Infectious Diseases, 2010
Mucocutaneous is an infection caused by a single celled parasite transmitted by sand fly bites. There are about 20 species of Leishmania that may cause mucocutaneous leishmaniasis.
Emilio Palumbo
doaj   +3 more sources

Complete Resolution of Cutaneous Leishmaniasis With a Novel Topical Combination Therapy: A Case Series. [PDF]

Clin Case Rep
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Haghshenas H, Ghanaatpisheh A, Darayesh M, Entezar Almahdi E.   +3 more
europepmc   +2 more sources

Efficacy and Safety of Topical Dapsone in Dermatology: A Scoping Review of Clinical Studies. [PDF]

J Cosmet Dermatol
ABSTRACT Background Dapsone (4,4′‐Diamino diphenyl sulfone) has been utilized in managing a wide variety of mucocutaneous conditions, usually as a systemic product. Topical dapsone is commercially available as 5% and 7.5% gel and is FDA‐approved for acne vulgaris.
Abtahi-Naeini B, Sattari H, Afshar K, Rastegarnasab F, Pourmahdi-Boroujeni M.   +4 more
europepmc   +2 more sources

Cheilitis: An unusual presentation of Mucocutaneous Leishmaniasis [PDF]

Clinical Case Reports, 2018
Key Clinical Message The Mucocutaneous Leishmaniasis (MCL) involving lip is extremely uncommon. A clinical diagnosis of Leishmaniasis of the lips is often challenging to the treating clinician and may result in delayed diagnosis as this case illustrates.
Vathulan Sujanitha, Thirunavukarasu Kumanan, Srisaravanapavananthan Felicia, Navaneethakrishnan Suganthan   +3 more
doaj   +3 more sources

Mucocutaneous Leishmaniasis With Oral Involvement: A Case Report [PDF]

Case Reports in Dentistry
The primary objective of the present study is the retrospective analysis of a clinical case of oral leishmaniasis treated at Parma Hospital and a review of the literature on mucosal leishmaniasis (ML) with oral cavity involvement. We report the case of a
Pierpaolo De Francesco, Paolo Vescovi, Claudio Feliciani, Roberta Iaria, Luigi Corcione, Ilaria Giovannacci   +5 more
doaj   +2 more sources

A case of laryngeal leishmaniasis presenting as hoarseness in an Ethiopian patient: a case report [PDF]

Journal of Medical Case Reports
Background Leishmaniasis is a zoonotic disease caused by unicellular protozoa of the Leishmania genus. The infection can spread through zoonotic or anthroponotic transmission, depending on the species, with the phlebotomine sandfly serving as the primary
Mohammedsefa Arusi Dari, Zelalem Tadesse Wondimu, Melaku Abay Muluneh, Martha Mekonen Gdey, Adil Fekede Ayele   +4 more
doaj   +2 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Actas Dermo-Sifiliográficas (English Edition), 2021
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also
I, Abadías-Granado, A, Diago, P A, Cerro, A M, Palma-Ruiz, Y, Gilaberte   +4 more
openaire   +6 more sources

Espundia: a tropical infectious disease making its way to Europe. A case report of nasal mucocutaneous leishmaniasis in the Netherlands [PDF]

Rhinology Online, 2020
Background: We present a case history of a patient with nasal mucocutaneous leishmaniasis, also known as Espundia. Knowledge of this tropical infectious disease is usually limited among otorhinolaryngologists, but is of importance because patients may ...
A.A. Schenck, A.C. Westgeest, E.J.C. Teunissen, E.F. Schippers, J.P. Koopman   +4 more
doaj   +1 more source